Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GSK2190915 on allergen-induced early asthmatic response in mild asthma (3-period crossover)
2008-005205-19Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fiboflapon in asthma and allergic asthma (3 arms), sponsored by GSK. Primary endpoint: Early Asthmatic Response (EAR). Started Nov 2008; status: completed.
02
Drugs
fiboflapon
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2008-005205-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005205-19.